These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

636 related articles for article (PubMed ID: 25958657)

  • 41. [Anti-doping control and public health: limits to the exposure of human health to risk in the name of sporting glory].
    Aith FM
    Rev Saude Publica; 2013 Oct; 47(5):1015-8. PubMed ID: 24626509
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Doping droops.
    Chaturvedi A; Chaturvedi H; Kalra J; Kalra S
    Indian J Physiol Pharmacol; 2007; 51(2):118-30. PubMed ID: 18175655
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Athlete Biological Passport: How to Personalize Anti-Doping Testing across an Athlete's Career?
    Robinson N; Sottas PE; Schumacher YO
    Med Sport Sci; 2017; 62():107-118. PubMed ID: 28578329
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Performance enhancing drugs in sports and the role of doctors: are there guidelines?
    Prakash K
    Indian J Med Ethics; 2013; 10(2):115-7. PubMed ID: 23697492
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Implementation of the biological passport: the experience of the International Cycling Union.
    Zorzoli M; Rossi F
    Drug Test Anal; 2010; 2(11-12):542-7. PubMed ID: 21204287
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Doping control from a global and national perspective.
    Fraser AD
    Ther Drug Monit; 2004 Apr; 26(2):171-4. PubMed ID: 15228160
    [TBL] [Abstract][Full Text] [Related]  

  • 47. World anti-doping regulations for 2005: essential changes for athletes and physicians.
    Pabinger C; Gruber G
    Arch Orthop Trauma Surg; 2006 May; 126(4):286-8. PubMed ID: 16333634
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glucocorticoids in elite sport: current status, controversies and innovative management strategies-a narrative review.
    Vernec A; Slack A; Harcourt PR; Budgett R; Duclos M; Kinahan A; Mjøsund K; Strasburger CJ
    Br J Sports Med; 2020 Jan; 54(1):8-12. PubMed ID: 31326919
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Landscape of the "Spirit of Sport" : A Systematic Review.
    Obasa M; Borry P
    J Bioeth Inq; 2019 Sep; 16(3):443-453. PubMed ID: 31444642
    [TBL] [Abstract][Full Text] [Related]  

  • 50. International Sports Federation's fight to protect the clean athlete: are we doing enough in the fight against doping?
    Mountjoy M; Miller S; Vallini M; Foster J; Carr J
    Br J Sports Med; 2017 Sep; 51(17):1241-1242. PubMed ID: 28659359
    [No Abstract]   [Full Text] [Related]  

  • 51. Narrowing the gap between the number of athletes who dope and the number of athletes who are caught: scientific advances that increase the efficacy of antidoping tests.
    Botrè F; de la Torre X; Donati F; Mazzarino M
    Br J Sports Med; 2014 May; 48(10):833-6. PubMed ID: 24668049
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Scientific expertise and the Athlete Biological Passport: 3 years of experience.
    Schumacher YO; d'Onofrio G
    Clin Chem; 2012 Jun; 58(6):979-85. PubMed ID: 22490304
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The necessary dialogue between medicine and anti-doping for the integrity of sport and the athlete].
    Faiss R; Salamin O; Astolfi T; Saugy M
    Rev Med Suisse; 2018 Jul; 14(613):1360-1363. PubMed ID: 29998639
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ethics of a relaxed antidoping rule accompanied by harm-reduction measures.
    Kayser B; Tolleneer J
    J Med Ethics; 2017 May; 43(5):282-286. PubMed ID: 28154003
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anabolic agents: recent strategies for their detection and protection from inadvertent doping.
    Geyer H; Schänzer W; Thevis M
    Br J Sports Med; 2014 May; 48(10):820-6. PubMed ID: 24632537
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Moral Foundation for Anti-Doping: How Far Have We Progressed? Where Are the Limits?
    Murray TH
    Med Sport Sci; 2017; 62():186-193. PubMed ID: 28571014
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The world anti-doping program and the primary care physician.
    Hilderbrand RL
    Pediatr Clin North Am; 2007 Aug; 54(4):701-11, x-xi. PubMed ID: 17723872
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Performance-enhancing substances in sports: a review of the literature.
    Momaya A; Fawal M; Estes R
    Sports Med; 2015 Apr; 45(4):517-31. PubMed ID: 25663250
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An (un)desirable trade of harms? How elite athletes might react to medically supervised 'doping' and their considerations of side-effects in this situation.
    Overbye M
    Int J Drug Policy; 2018 May; 55():14-30. PubMed ID: 29477956
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Opinion paper: scientific, philosophical and legal consideration of doping in sports.
    Negro M; Marzullo N; Caso F; Calanni L; D'Antona G
    Eur J Appl Physiol; 2018 Apr; 118(4):729-736. PubMed ID: 29427238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.